First Time Loading...

Vita 34 AG
XETRA:V3V

Watchlist Manager
Vita 34 AG Logo
Vita 34 AG
XETRA:V3V
Watchlist
Price: 5.15 EUR 6.4% Market Closed
Updated: Apr 27, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Vita 34 AG

Revenue
74.9m EUR
Cost of Revenue
-64.2m EUR
Gross Profit
10.7m EUR
Operating Expenses
-32.8m EUR
Operating Income
-22.1m EUR
Other Expenses
-2.8m EUR
Net Income
-24.9m EUR

Margins Comparison
Vita 34 AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DE
Vita 34 AG
XETRA:V3V
81.5m EUR
14%
-30%
-33%
US
Cigna Group
XMUN:CGN
96.6B EUR
13%
5%
3%
US
Cigna Corp
NYSE:CI
103.7B USD
13%
5%
3%
US
CVS Health Corp
NYSE:CVS
86.5B USD
15%
4%
2%
DE
Fresenius Medical Care AG
XMUN:FME
22.2B EUR
25%
7%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.7B USD
28%
9%
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.3B EUR
23%
5%
-3%
US
Quest Diagnostics Inc
NYSE:DGX
14.9B USD
33%
14%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11B EUR
25%
7%
3%
US
DaVita Inc
NYSE:DVA
11.9B USD
31%
13%
6%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
4%
-22%
-24%
Country DE
Market Cap 81.5m EUR
Gross Margin
14%
Operating Margin
-30%
Net Margin
-33%
Country US
Market Cap 96.6B EUR
Gross Margin
13%
Operating Margin
5%
Net Margin
3%
Country US
Market Cap 103.7B USD
Gross Margin
13%
Operating Margin
5%
Net Margin
3%
Country US
Market Cap 86.5B USD
Gross Margin
15%
Operating Margin
4%
Net Margin
2%
Country DE
Market Cap 22.2B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 16.7B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
4%
Country DE
Market Cap 15.3B EUR
Gross Margin
23%
Operating Margin
5%
Net Margin
-3%
Country US
Market Cap 14.9B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country DE
Market Cap 11B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country US
Market Cap 11.9B USD
Gross Margin
31%
Operating Margin
13%
Net Margin
6%
Country US
Market Cap 9.5B USD
Gross Margin
4%
Operating Margin
-22%
Net Margin
-24%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Vita 34 AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Vita 34 AG
XETRA:V3V
81.5m EUR
-104%
-15%
-22%
-16%
US
Cigna Group
XMUN:CGN
96.6B EUR
11%
3%
9%
7%
US
Cigna Corp
NYSE:CI
103.7B USD
11%
3%
9%
7%
US
CVS Health Corp
NYSE:CVS
86.5B USD
11%
3%
9%
6%
DE
Fresenius Medical Care AG
XMUN:FME
22.2B EUR
4%
1%
4%
3%
US
Laboratory Corporation of America Holdings
NYSE:LH
16.7B USD
5%
2%
7%
4%
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.3B EUR
-3%
-1%
2%
1%
US
Quest Diagnostics Inc
NYSE:DGX
14.9B USD
14%
6%
11%
8%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11B EUR
4%
1%
4%
3%
US
DaVita Inc
NYSE:DVA
11.9B USD
78%
4%
11%
8%
US
Oak Street Health Inc
NYSE:OSH
9.5B USD
464%
-26%
-41%
-35%
Country DE
Market Cap 81.5m EUR
ROE
-104%
ROA
-15%
ROCE
-22%
ROIC
-16%
Country US
Market Cap 96.6B EUR
ROE
11%
ROA
3%
ROCE
9%
ROIC
7%
Country US
Market Cap 103.7B USD
ROE
11%
ROA
3%
ROCE
9%
ROIC
7%
Country US
Market Cap 86.5B USD
ROE
11%
ROA
3%
ROCE
9%
ROIC
6%
Country DE
Market Cap 22.2B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country US
Market Cap 16.7B USD
ROE
5%
ROA
2%
ROCE
7%
ROIC
4%
Country DE
Market Cap 15.3B EUR
ROE
-3%
ROA
-1%
ROCE
2%
ROIC
1%
Country US
Market Cap 14.9B USD
ROE
14%
ROA
6%
ROCE
11%
ROIC
8%
Country DE
Market Cap 11B EUR
ROE
4%
ROA
1%
ROCE
4%
ROIC
3%
Country US
Market Cap 11.9B USD
ROE
78%
ROA
4%
ROCE
11%
ROIC
8%
Country US
Market Cap 9.5B USD
ROE
464%
ROA
-26%
ROCE
-41%
ROIC
-35%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More